VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 111 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,912,000 | -41.6% | 310,354 | -48.3% | 0.04% | -48.8% |
| Q1 2018 | $10,116,000 | +57.0% | 600,354 | +41.6% | 0.09% | +53.6% |
| Q4 2017 | $6,443,000 | -15.1% | 423,884 | 0.0% | 0.06% | -9.7% |
| Q3 2017 | $7,588,000 | +45.9% | 423,884 | +3.4% | 0.06% | +34.8% |
| Q2 2015 | $5,201,000 | -68.0% | 409,881 | -76.6% | 0.05% | -65.9% |
| Q1 2015 | $16,277,000 | -74.6% | 1,750,230 | -60.9% | 0.14% | -79.4% |
| Q4 2014 | $64,041,000 | +41.1% | 4,472,153 | +2.3% | 0.65% | +14.3% |
| Q3 2014 | $45,383,000 | -35.8% | 4,372,153 | 0.0% | 0.57% | -33.9% |
| Q2 2014 | $70,741,000 | -2.1% | 4,372,153 | -1.7% | 0.87% | -5.7% |
| Q1 2014 | $72,243,000 | +21.5% | 4,445,696 | -7.2% | 0.92% | +9.5% |
| Q4 2013 | $59,459,000 | +13.3% | 4,791,179 | 0.0% | 0.84% | +12.3% |
| Q3 2013 | $52,463,000 | +63.7% | 4,791,179 | +20.8% | 0.75% | +17.7% |
| Q2 2013 | $32,047,000 | – | 3,966,179 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |